My clinical expertise is in gynecologic malignancies and my research program focuses on clinical trials and translation research of these cancers. I have experience in conducting clinical trials of experimental therapeutics in molecularly distinct cancer subtypes. As an active member of the NCIC-CTG I have lead a national phase II trial of temsirolimus in metastatic cervical cancer. I am also a contributor to the landmark work defining the distinct molecular subtypes of high grade ovarian cancers .
I have ongoing interests clinical trial development for patients with gynecologic malignancies. I work closely with basic scientists on projects in the areas of molecular cancer therapy as well as immunologic cancer therapy.